Multicentric study on surgical information and early safety and performance results with the Bonebridge BCI 602: an active transcutaneous bone conduction hearing implant.
Georg Mathias SprinzlJoseph TonerAssen KoitschevNadine BergerThomas KeintzelThomas RasseWolf-Dieter BaumgartnerClemens HonederAstrid MageleStefan K PlontkeGerrit GötzeSchmutzhard JoachimPhilipp ZelgerStephanie CorkillThomas LenarzRolf SalcherPublished in: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery (2023)
The Bonebridge BCI 602 significantly improved hearing thresholds and speech understanding. Since implant placement follows the patient's anatomy instead of the shape of the device and the duration of surgery is shorter than with its predecessor, implantation is easier with the BCI 602. Performance and safety were proven for adults and children as well as for the CHL/MHL and SSD indications 3 months post-operatively.